Maria Sormani to Brain
This is a "connection" page, showing publications Maria Sormani has written about Brain.
Connection Strength
0.898
-
Cerebellar volume as imaging outcome in progressive multiple sclerosis. PLoS One. 2017; 12(4):e0176519.
Score: 0.197
-
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. Mult Scler. 2018 02; 24(2):222-226.
Score: 0.194
-
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients. Mult Scler Relat Disord. 2016 May; 7:98-101.
Score: 0.183
-
Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL. J Neurol. 2018 May; 265(5):1158-1165.
Score: 0.052
-
Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL-a longitudinal brain volumetry study in healthy adults. Neurobiol Aging. 2018 05; 65:1-6.
Score: 0.052
-
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study. Brain. 2017 Nov 01; 140(11):2814-2819.
Score: 0.051
-
Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials. Neurotherapeutics. 2017 Oct; 14(4):924-933.
Score: 0.051
-
Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease. J Neuroimaging. 2017 11; 27(6):613-619.
Score: 0.049
-
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis. Neuroimage Clin. 2014; 4:641-8.
Score: 0.040
-
Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg Psychiatry. 2000 Dec; 69(6):723-7.
Score: 0.016
-
Should frequent MRI monitoring be performed in natalizumab-treated MS patients? A contribution to a recent debate. Mult Scler. 2020 09; 26(10):1227-1236.
Score: 0.014